Literature DB >> 20194705

Interaction of Candida albicans biofilms with antifungals: transcriptional response and binding of antifungals to beta-glucans.

Govindsamy Vediyappan1, Tristan Rossignol, Christophe d'Enfert.   

Abstract

Candida albicans can form biofilms that exhibit elevated intrinsic resistance to various antifungal agents, in particular azoles and polyenes. The molecular mechanisms involved in the antifungal resistance of biofilms remain poorly understood. We have used transcript profiling to explore the early transcriptional responses of mature C. albicans biofilms exposed to various antifungal agents. Mature C. albicans biofilms grown under continuous flow were exposed for as long as 2 h to concentrations of fluconazole (FLU), amphotericin B (AMB), and caspofungin (CAS) that, while lethal for planktonic cells, were not lethal for biofilms. Interestingly, FLU-exposed biofilms showed no significant changes in gene expression over the course of the experiment. In AMB-exposed biofilms, 2.7% of the genes showed altered expression, while in CAS-exposed biofilms, 13.0% of the genes had their expression modified. In particular, exposure to CAS resulted in the upregulation of hypha-specific genes known to play a role in biofilm formation, such as ALS3 and HWP1. There was little overlap between AMB- or CAS-responsive genes in biofilms and those that have been identified as AMB, FLU, or CAS responsive in C. albicans planktonic cultures. These results suggested that the resistance of C. albicans biofilms to azoles or polyenes was due not to the activation of specific mechanisms in response to exposure to these antifungals but rather to the intrinsic properties of the mature biofilms. In this regard, our study led us to observe that AMB physically bound C. albicans biofilms and beta-glucans, which have been proposed to be major constituents of the biofilm extracellular matrix and to prevent azoles from reaching biofilm cells. Thus, enhanced extracellular matrix or beta-glucan synthesis during biofilm growth might prevent antifungals, such as azoles and polyenes, from reaching biofilm cells, thus limiting their toxicity to these cells and the associated transcriptional responses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20194705      PMCID: PMC2863626          DOI: 10.1128/AAC.01638-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  75 in total

Review 1.  Epidemiology of opportunistic invasive mycoses.

Authors:  B J Kullberg; A M L Oude Lashof
Journal:  Eur J Med Res       Date:  2002-05-31       Impact factor: 2.175

2.  Cloning of the Candida albicans homolog of Saccharomyces cerevisiae GSC1/FKS1 and its involvement in beta-1,3-glucan synthesis.

Authors:  T Mio; M Adachi-Shimizu; Y Tachibana; H Tabuchi; S B Inoue; T Yabe; T Yamada-Okabe; M Arisawa; T Watanabe; H Yamada-Okabe
Journal:  J Bacteriol       Date:  1997-07       Impact factor: 3.490

3.  A multifunctional, synthetic Gaussia princeps luciferase reporter for live imaging of Candida albicans infections.

Authors:  Brice Enjalbert; Anna Rachini; Govindsamy Vediyappan; Donatella Pietrella; Roberta Spaccapelo; Anna Vecchiarelli; Alistair J P Brown; Christophe d'Enfert
Journal:  Infect Immun       Date:  2009-08-17       Impact factor: 3.441

4.  Comparison of three assays for the quantification of Candida biomass in suspension and CDC reactor grown biofilms.

Authors:  Kris Honraet; Els Goetghebeur; Hans J Nelis
Journal:  J Microbiol Methods       Date:  2005-06-02       Impact factor: 2.363

5.  International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group (Europe).

Authors:  M A Pfaller; R N Jones; G V Doern; A C Fluit; J Verhoef; H S Sader; S A Messer; A Houston; S Coffman; R J Hollis
Journal:  Diagn Microbiol Infect Dis       Date:  1999-09       Impact factor: 2.803

6.  Candida albicans Als3p is required for wild-type biofilm formation on silicone elastomer surfaces.

Authors:  Xiaomin Zhao; Karla J Daniels; Soon-Hwan Oh; Clayton B Green; Kathleen M Yeater; David R Soll; Lois L Hoyer
Journal:  Microbiology (Reading)       Date:  2006-08       Impact factor: 2.777

7.  The CRH family coding for cell wall glycosylphosphatidylinositol proteins with a predicted transglycosidase domain affects cell wall organization and virulence of Candida albicans.

Authors:  Giacomo Pardini; Piet W J De Groot; Alix T Coste; Mahir Karababa; Frans M Klis; Chris G de Koster; Dominique Sanglard
Journal:  J Biol Chem       Date:  2006-10-30       Impact factor: 5.157

8.  Candida albicans biofilms: a developmental state associated with specific and stable gene expression patterns.

Authors:  Susana García-Sánchez; Sylvie Aubert; Ismaïl Iraqui; Guilhem Janbon; Jean-Marc Ghigo; Christophe d'Enfert
Journal:  Eukaryot Cell       Date:  2004-04

9.  The GPI-modified proteins Pga59 and Pga62 of Candida albicans are required for cell wall integrity.

Authors:  Emilia Moreno-Ruiz; Giuseppe Ortu; Piet W J de Groot; Fabien Cottier; Céline Loussert; Marie-Christine Prévost; Chris de Koster; Frans M Klis; Sophie Goyard; Christophe d'Enfert
Journal:  Microbiology       Date:  2009-04-21       Impact factor: 2.777

10.  Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols.

Authors:  Pranab K Mukherjee; Jyotsna Chandra; Duncan M Kuhn; Mahmoud A Ghannoum
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

View more
  62 in total

1.  In vitro activities of anidulafungin and other antifungal agents against biofilms formed by clinical isolates of different Candida and Aspergillus species.

Authors:  Barbara Fiori; Brunella Posteraro; Riccardo Torelli; Mario Tumbarello; David S Perlin; Giovanni Fadda; Maurizio Sanguinetti
Journal:  Antimicrob Agents Chemother       Date:  2011-03-21       Impact factor: 5.191

2.  Large-scale production and isolation of Candida biofilm extracellular matrix.

Authors:  Robert Zarnowski; Hiram Sanchez; David R Andes
Journal:  Nat Protoc       Date:  2016-10-27       Impact factor: 13.491

3.  Global transcriptome changes underlying colony growth in the opportunistic human pathogen Aspergillus fumigatus.

Authors:  John G Gibbons; Anne Beauvais; Remi Beau; Kriston L McGary; Jean-Paul Latgé; Antonis Rokas
Journal:  Eukaryot Cell       Date:  2011-07-01

Review 4.  Fungal biofilms, drug resistance, and recurrent infection.

Authors:  Jigar V Desai; Aaron P Mitchell; David R Andes
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-01       Impact factor: 6.915

5.  Fungal β-1,3-glucan increases ofloxacin tolerance of Escherichia coli in a polymicrobial E. coli/Candida albicans biofilm.

Authors:  Katrijn De Brucker; Yulong Tan; Katlijn Vints; Kaat De Cremer; Annabel Braem; Natalie Verstraeten; Jan Michiels; Jef Vleugels; Bruno P A Cammue; Karin Thevissen
Journal:  Antimicrob Agents Chemother       Date:  2015-03-09       Impact factor: 5.191

Review 6.  Mechanisms of Candida biofilm drug resistance.

Authors:  Heather T Taff; Kaitlin F Mitchell; Jessica A Edward; David R Andes
Journal:  Future Microbiol       Date:  2013-10       Impact factor: 3.165

7.  In vitro interactions between aspirin and amphotericin B against planktonic cells and biofilm cells of Candida albicans and C. parapsilosis.

Authors:  Yabin Zhou; Ganggang Wang; Yutang Li; Yang Liu; Yu Song; Wenshuai Zheng; Ning Zhang; Xiaoyan Hu; Shikun Yan; Jihui Jia
Journal:  Antimicrob Agents Chemother       Date:  2012-03-05       Impact factor: 5.191

8.  Addition of DNase improves the in vitro activity of antifungal drugs against Candida albicans biofilms.

Authors:  Margarida Martins; Mariana Henriques; José L Lopez-Ribot; Rosário Oliveira
Journal:  Mycoses       Date:  2011-06-12       Impact factor: 4.377

9.  Interface of Candida albicans biofilm matrix-associated drug resistance and cell wall integrity regulation.

Authors:  Jeniel E Nett; Hiram Sanchez; Michael T Cain; Kelly M Ross; David R Andes
Journal:  Eukaryot Cell       Date:  2011-06-10

10.  Role of matrix β-1,3 glucan in antifungal resistance of non-albicans Candida biofilms.

Authors:  K F Mitchell; H T Taff; M A Cuevas; E L Reinicke; H Sanchez; D R Andes
Journal:  Antimicrob Agents Chemother       Date:  2013-01-14       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.